Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1
Targeted protein degradation using proteolysis-targeting chimeras (PROTACs) has emerged as a powerful strategy for disease treatment. By recruiting E3 ligases, these molecules enable selective degradation of pathogenic proteins. Cereblon (CRBN), a key component of the CUL4-DDB1-CRBN E3 ligase complex, is the most commonly recruited E3 ligase in PROTACs, including those targeting histone deacetylases (HDACs). In this study, we designed <b>SZ-2</b>, a bifunctional molecule derived from the DDB1 ligand MM-02-57 and the HDAC inhibitor vorinostat, to simultaneously bind DDB1 and HDACs. <b>SZ-2</b> effectively induced degradation of HDAC1 and HDAC2 and demonstrated potent anti-multiple myeloma activity, highlighting its potential as a novel therapeutic agent.
Authors
- Finn K. Hansen (ORCID: https://orcid.org/0000-0001-9765-5975)
- Tao Sun (ORCID: https://orcid.org/0000-0002-2800-0921)
- Shixin Deng (ORCID: https://orcid.org/0000-0002-3947-7629)
- Shiyang Zhai (ORCID: https://orcid.org/0009-0005-6840-3177)
- Matthias Geyer (ORCID: https://orcid.org/0000-0002-7718-5002)
- Nicola Willemsen (ORCID: https://orcid.org/0009-0001-0579-0844)
- Mateo Malenica
Institutions
- University of Bonn (DE)
- Institute of Cell Biology (UA)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00506
- Citations
- 1
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81